Darius Mason, Pharm.D., BCPS



Nephrology Pharmacotherapy Fellowship, University of Illinois at Chicago, Chicago, IL
Internal Medicine Residency, Methodist Le Bonheur Healthcare, Memphis, TN
Pharm.D., University of Tennessee

Adjunct Appointments

Assistant Professor - Department of Medicine (Division of Nephrology)
Albany Medical College, Albany, NY

Courses Taught at ACPHS

PTPM 525 – Nephrology Module – Mineral and Bone Disease 
Principles of Pharmacogenomics
Clinical clerkships: Ambulatory Hemodialysis Unit

Research Interests

Evaluation of pharmacotherapy on vascular calcification markers in chronic kidney disease
Vitamin D and phosphorus metabolism in healthy and chronic kidney disease
Biomarkers of neurology in chronic kidney disease

Currently Funded Clinical Studies

"Sustainability of serum [25OHD] levels, inflammatory reduction, and endothelial dysfunction after repletion with ergocalciferol in CKD Stage 5D." NCT01312441

"A Randomized Study on the Effects of Sevelamer Carbonate versus Calcium Acetate on Biomarkers of Vascular Calcification, Inflammation, and Endothelial Dysfunction in Chronic Kidney Disease Stages 3 and 4."  NCT01277497

Selected Publications

Mason DL, Assimon MA, Bishop JB, El-Fawal HA. Nervous System Autoantibodies and Vitamin D Receptor Gene Polymorphisms in Hemodialysis Patients. Hemodial Int. 2012.

How PP, Anattiwong P, Mason DL, Arruda JA, Lau AH. Phosphate-binding efficacy of crushed vs. chewed lanthanum carbonate in hemodialysis patients. Hemodial Int. 2011; 15:95-99.

Assimon MA, Salenger PA, El-Fawal HA, Mason DL. Nutritional vitamin D supplementation in hemodialysis: a potential vascular benefit? Nephrology (Carlton). 2011;17(3):237-242.

Hudson JQ, Mason DL, Huch K. Estimates of Kidney Function in Obese African-Americans with Kidney Disease. Nephron Clin Pract 2011;118:c101-c108.

How PP, Mason DL, Arruda JA, Lau AH. Efficacy of Chewed vs. Crushed Lanthanum on Phosphorus Binding in Healthy Volunteers. Clin Nephrol; 2010:370-373.

Mason DL, Best SD. Contemporary Pharmacotherapy: Calcific Uremic Arteriolopathy. Advances in Chronic Kidney Disease Vol 17, No 5, 2010: pp 428-438.

How PP, Mason DL, Lau AH. Current Approaches in the Treatment of Chronic Kidney Disease Mineral and Bone Disease Disorder. Journal of Pharmacy Practice 2008 21: 196-213.

Assistant Professor
Department of Pharmacy Practice